Arvind K. Virmani
- Molecular Biology top 2%
- Oncology top 2%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 2%
- Genetics top 2%
- Co-authors
- Adi F. GazdarJohn D. MinnaIgnacio I. WistubaShinichi ToyookaKiyomi O. ToyookaKwun M. FongSara MilchgrubSabine Zöchbauer‐Müller
- Topics
- Epigenetics and DNA Methylation (12 papers)Cancer-related gene regulation (8 papers)RNA modifications and cancer (8 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Medicine
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Arvind K. Virmani
43 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 3.4k
- Oncology 1.4k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 844
- Genetics 738
Countries citing papers authored by Arvind K. Virmani
This map shows the geographic impact of Arvind K. Virmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arvind K. Virmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arvind K. Virmani more than expected).
Fields of papers citing papers by Arvind K. Virmani
This network shows the impact of papers produced by Arvind K. Virmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arvind K. Virmani. The network helps show where Arvind K. Virmani may publish in the future.
Co-authorship network of co-authors of Arvind K. Virmani
This figure shows the co-authorship network connecting the top 25 collaborators of Arvind K. Virmani. A scholar is included among the top collaborators of Arvind K. Virmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arvind K. Virmani. Arvind K. Virmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 27 | |
| 3 | 39 | |
| 4 | 116 | |
| 5 | 230 | |
| 6 | 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. | 218 |
| 7 | 424 | |
| 8 | 123 | |
| 9 | 152 | |
| 10 | 57 | |
| 11 | 242 | |
| 12 | 168 | |
| 13 | 30 | |
| 14 | 166 | |
| 15 | FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. | 170 |
| 16 | Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. | 148 |
| 17 | 55 | |
| 18 | 122 | |
| 19 | 23 | |
| 20 | 3 |
About Arvind K. Virmani
Arvind K. Virmani is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 43 papers that have together received 4.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), Cancer-related gene regulation (8 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations) and Molecular Biology (3.4k citations). Arvind K. Virmani has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Adi F. Gazdar, John D. Minna, Ignacio I. Wistuba, Shinichi Toyooka, Kiyomi O. Toyooka, Kwun M. Fong, Sara Milchgrub, Sabine Zöchbauer‐Müller, Kenji Sugio and Riichiroh Maruyama. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.